How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Learn how to invest in stocks, including how to choose the right stock investment for you, how to manage your portfolio and the steps in between. Many, or all, of the products featured on this page ...

Ready to get started with points and miles? Here's what you need to know.